Getting Weight Loss Medication Online: What to Expect, Costs, and Eligibility

You can get weight loss medication online by completing a telehealth visit with a licensed clinician who reviews your health history, BMI, and goals. If eligible, they can prescribe an FDA-approved GLP-1 such as semaglutide or tirzepatide, or a compounded alternative from a 503A pharmacy, shipped to your door [1,2,3].

Can you really get weight loss medication online?

Yes. Weight loss medication can be prescribed online when a licensed clinician evaluates you and decides treatment is medically appropriate. Telehealth does not remove the need for a real medical review, and prescriptions still must be filled by a licensed pharmacy [9,12].

What telehealth can and cannot do

Telehealth can collect your health history, current medications, allergies, weight, height, goals, and sometimes lab results. A clinician can decide whether a prescription is appropriate, monitor side effects, and adjust the care plan over time [9,12].

Telehealth cannot safely skip screening. A good provider should ask about pregnancy, pancreatitis history, gallbladder disease, kidney disease, eating disorder history, diabetes medicines, and thyroid cancer risk before considering GLP-1 treatment [1,2,13].

Which medications are legally available online

Online clinicians may prescribe FDA-approved anti-obesity medications when the patient meets label criteria. These include Wegovy (semaglutide, a GLP-1 receptor agonist; also available as compounded semaglutide via 503A pharmacy when legally appropriate), Zepbound (tirzepatide, a GIP/GLP-1 dual agonist; also available as compounded tirzepatide via 503A pharmacy when legally appropriate), Saxenda (liraglutide), Contrave (bupropion-naltrexone), and orlistat products such as Xenical and Alli [1,2,4,5,6].

Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved for type 2 diabetes, not chronic weight management. If a clinician discusses them for weight loss, that is an off-label topic and should be handled as individualized medical decision-making, not a guaranteed or one-size-fits-all path [7,8].

Who is eligible for online weight loss medication?

Eligibility depends on your BMI, health conditions, medication history, age, state rules, and the clinician’s judgment. For several FDA-approved weight loss medications, label criteria include BMI 30 or higher or BMI 27 or higher with a weight-related condition [1,2,4,5].

BMI and weight-related conditions

BMI means body mass index, a height-and-weight screening tool. FDA labels for Wegovy, Zepbound, and Saxenda include adults with obesity, or adults with overweight plus at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol [1,2,4].

Obesity and overweight are clinical conditions, not character flaws. Major medical groups describe obesity as a chronic disease influenced by biology, environment, medications, sleep, stress, and genetics [13].

Medical history that may disqualify you

GLP-1 and GIP/GLP-1 medications are not right for everyone. Wegovy and Zepbound carry boxed warnings about thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [1,2].

A clinician may also be cautious if you are pregnant, planning pregnancy, breastfeeding, have a history of pancreatitis, severe gastrointestinal disease, gallbladder disease, kidney problems, or take medicines that can cause low blood sugar. These risks are described in FDA labeling and should be reviewed before prescribing [1,2,7,8].

Age and state restrictions

Some anti-obesity medicines have pediatric indications, but many online programs treat adults only. Telehealth rules, pharmacy shipping rules, and clinician licensing also vary by state, so a provider may not be able to treat every patient in every location [1,2,9].

What weight loss medications can be prescribed online?

Online care can include injectable GLP-1 medicines, oral medicines, or non-GLP-1 options when appropriate. Semaglutide and tirzepatide have strong modern trial data for average weight loss, but they also carry important side effects, contraindications, cost, and access limits [14,15].

Brand-name GLP-1s: Wegovy and Zepbound

Wegovy (semaglutide) is FDA-approved for chronic weight management in certain adults and adolescents and for reducing the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight [1]. In the STEP 1 trial, participants received semaglutide 2.4 mg once weekly; it was associated with greater average weight loss than placebo, but nausea, diarrhea, vomiting, and constipation were common, and individual results varied [14].

Zepbound (tirzepatide) is FDA-approved for chronic weight management in certain adults with obesity or overweight and for moderate-to-severe obstructive sleep apnea in adults with obesity [2]. In SURMOUNT-1, participants received tirzepatide once weekly at study-assigned doses; it was associated with greater average weight loss than placebo, but gastrointestinal side effects were common and the medication has a boxed thyroid C-cell tumor warning [2,15].

Oral options: oral semaglutide and orforglipron

Rybelsus (oral semaglutide) is FDA-approved for type 2 diabetes, not chronic weight management. Higher-dose oral semaglutide has been studied for weight management, but patients should not assume a diabetes tablet is an approved weight loss medication unless the FDA label says so; oral semaglutide can also cause gastrointestinal side effects and has GLP-1 class warnings [16,17].

Orforglipron, sometimes discussed with the proposed brand name Foundayo, is an oral GLP-1 receptor agonist that has been studied in clinical trials for obesity. It is not FDA-approved for weight management at the time of this article, so it should be viewed as investigational unless FDA approval status changes; in trials, gastrointestinal side effects were common and long-term labeling limits are not yet established [18,22].

Other FDA-approved options: Saxenda, Contrave, and orlistat

Saxenda (liraglutide) is a GLP-1 receptor agonist approved for chronic weight management in certain adults and adolescents. The FDA-approved Saxenda label describes once-daily injection and class warnings such as thyroid C-cell tumor risk, along with common gastrointestinal side effects [4].

Contrave (bupropion-naltrexone) is an oral medication approved for chronic weight management in certain adults. It has a boxed warning for suicidal thoughts and behaviors related to the bupropion component and is not appropriate for some people with seizure risk, uncontrolled hypertension, or chronic opioid use [5].

Orlistat is available as prescription Xenical and lower-dose over-the-counter Alli. It works in the gut by reducing absorption of some dietary fat, but it can cause oily stools, urgency, and reduced absorption of fat-soluble vitamins [6].

Compounded semaglutide and tirzepatide via 503A pharmacies

Compounded semaglutide and compounded tirzepatide are not FDA-approved. When legally appropriate, a state-licensed 503A pharmacy may prepare a compounded medication for an individual patient based on a valid prescription, but FDA does not review compounded drugs for safety, effectiveness, or quality before they are dispensed [10,11].

The FDA has warned patients not to use products marketed as semaglutide or tirzepatide from unverified sellers, especially products sold without a prescription or labeled as research chemicals. Side effects and contraindications still matter with compounded GLP-1s, including nausea, vomiting, diarrhea, dehydration risk, gallbladder problems, pancreatitis warnings, and thyroid tumor boxed warnings where applicable [1,2,10,11].

How does the online process work, step by step?

The online process usually has four parts: intake, clinician review, prescription decision, and follow-up. Telehealth prescribing still requires a licensed clinician and a pharmacy that can legally dispense the medication [9,12].

1. 1Intake questionnaire and health history: You share height, weight, medical conditions, medications, allergies, pregnancy status, past weight loss treatments, and goals.
2. 2Clinician review or video visit: A licensed clinician reviews whether treatment fits your history and state rules. Some cases may need a video visit, labs, or records.
3. 3Prescription and pharmacy dispensing: If eligible, the clinician may prescribe an FDA-approved medication or, when appropriate, a compounded option through a licensed pharmacy.
4. 4Delivery and follow-up check-ins: Medication may ship to your home if allowed. Follow-up visits help track side effects, weight trend, blood sugar risk, blood pressure, and whether the plan still fits.

A careful provider should explain benefits and trade-offs together. GLP-1 medicines can help with weight management in eligible patients, but they can also cause gastrointestinal side effects and are not appropriate for people with certain thyroid cancer risks [1,2,14,15].

How much does weight loss medication cost online?

Costs vary by medication, insurance, pharmacy, state, and visit fees. Brand-name GLP-1s can list above $1,000 per month, while insurance coverage, coupons, and compounded options may change the out-of-pocket price [19,20].

Cash pay for brand-name GLP-1s

Cash-pay costs for brand-name GLP-1s can be high because the list price does not include insurance discounts, coupons, or pharmacy-specific pricing. Manufacturer list price pages for Wegovy and Zepbound show why many patients check insurance coverage before starting [19,20].

With insurance and manufacturer coupons

Insurance may require prior authorization, proof of BMI criteria, documentation of weight-related conditions, or step therapy. Manufacturer savings programs may lower costs for eligible patients, but terms can change and often exclude some government insurance plans [19,20].

Compounded GLP-1 pricing

Compounded GLP-1 pricing is usually cash pay and may include the telehealth visit, pharmacy dispensing, supplies, and shipping. Compounded medications are not FDA-approved, so patients should ask which pharmacy is used, whether it is state-licensed, and what quality testing is performed [10,11].

How to get weight loss medication online through Chia

Chia is one licensed telehealth path among several. A patient can complete an online intake, have a clinician review eligibility, and, if appropriate, receive a prescription for a weight loss medication, including compounded GLP-1 options dispensed by licensed 503A pharmacy partners.

The same safety rules apply no matter which provider you choose. You should expect screening for BMI, medical history, contraindications, medication interactions, pregnancy status, side effects, and follow-up needs before any prescription decision [1,2,9,12].

Is it safe to get weight loss medication online?

It can be safe when the provider is legitimate, the clinician is licensed in your state, and the medication comes from a licensed pharmacy. Prescription GLP-1 medication should never be sold without a medical evaluation [9,10,12].

How to spot a legitimate telehealth provider

• They require a health history and clinician review before prescribing.
• They explain FDA approval status and whether a medication is compounded.
• They identify the dispensing pharmacy or pharmacy type.
• They screen for contraindications, pregnancy, drug interactions, and side effects.
• They offer follow-up care and a way to report side effects.
• They do not promise a specific amount of weight loss.

Red flags to avoid

• A website sells semaglutide or tirzepatide without a prescription.
• The product is labeled “research use only” but marketed for weight loss.
• The seller will not name a licensed pharmacy.
• The site promises guaranteed results or no side effects.
• The site uses fake before-and-after stories or pressures you to buy quickly.
• The medication is shipped from an unknown overseas source without a valid prescription.

Side effects and monitoring

Common GLP-1 side effects include nausea, vomiting, diarrhea, constipation, stomach pain, and reduced appetite. More serious label warnings include pancreatitis, gallbladder disease, kidney injury linked to dehydration, low blood sugar when used with certain diabetes medicines, and thyroid C-cell tumor warnings [1,2,7,8].

Monitoring helps keep benefits and risks in view. A clinician may track weight trend, symptoms, blood pressure, blood sugar risk, lab history, medication interactions, and whether side effects are manageable [1,2,13].

What should you expect after starting treatment?

Expect gradual changes, regular check-ins, and possible side effects, especially early in treatment. GLP-1 treatment is usually titrated over months in FDA labeling to improve tolerability, but your own plan must come from your clinician [1,2].

Typical dose titration schedule

The FDA-approved Wegovy label starts semaglutide at 0.25 mg once weekly for 4 weeks, then increases in steps until the maintenance dose of 1.7 mg or 2.4 mg once weekly is reached, depending on tolerability and clinical judgment [1].

The FDA-approved Zepbound label starts tirzepatide at 2.5 mg once weekly for 4 weeks, then increases to 5 mg once weekly, with later step increases available based on response and tolerability; the labeled maintenance doses include 5 mg, 10 mg, or 15 mg once weekly [2].

These are FDA-label schedules, not instructions for you to follow on your own. A clinician may pause, slow, stop, or change treatment if side effects, contraindications, pregnancy plans, lab findings, or other health issues arise [1,2].

Common side effects and how they are managed

Nausea, constipation, diarrhea, vomiting, and stomach discomfort are common with GLP-1 and GIP/GLP-1 medicines. Clinicians often manage these by reviewing meal size, hydration, constipation care, dose timing, and whether the medication should be held or adjusted [1,2].

Severe belly pain, repeated vomiting, dehydration, signs of gallbladder problems, allergic reaction symptoms, or low blood sugar symptoms need prompt medical advice. These warnings are included in FDA labeling for semaglutide and tirzepatide products [1,2,7,8].

How long you may stay on medication

Obesity is often chronic, so some people use medication long term when benefits continue to outweigh risks. In a randomized withdrawal trial, stopping semaglutide after initial treatment was followed by weight regain on average, while continued treatment maintained more of the weight loss; individual results varied, and side effects still required monitoring [21].

Long-term use should be reviewed with a clinician. The decision may depend on side effects, weight trend, blood pressure, blood sugar, cholesterol, cost, pregnancy plans, medication access, and personal goals [1,2,13].

Frequently asked questions

Keep reading

Weight Loss Medication

How to Get Weight Loss Drugs: A Step-by-Step Patient Guide

Weight Loss

How to Get Weight Loss Medication: Eligibility, Options, and Costs

GLP-1 Weight Loss

Weight Loss Prescriptions Online: How They Work and How to Qualify